Dr Jade Murray, Postdoctoral Research Fellow
Turner Institute for Brain and Mental Health, Monash University
VICTORIA, AUSTRALIA
Bench Side Story continues with a Postdoctoral Research Fellow at the Turner Institute for Brain and Mental Health, at Monash University in Melbourne, Victoria, AUSTRALIA.
Dr. Jade M. Murray completed a PhD programme at the Monash University Sleep and Circadian Medicine Laboratory in 2018. Dr. Murray’s broad research interests include studying the effects of circadian misalignment on overall health in both healthy and sleep disordered populations and developing simplified methods for determining the timing of circadian phase. An important innovation in her work has been tracking light-dark exposure data over time to build predictive models of circadian timing for development of personalised delivery systems for sleep-wake interventions to improve health and lifestyle outcomes.
-
CASE STUDY Large scale genetic study finds link between Irritable Bowel Syndrome & cardiovascular system
Research published April 2024 in the journal Cellular and Molecular Gastroenterology and Hepatology sheds light on disease mechanisms common to irritable bowel syndrome (IBS) and cardiovascular diseases (CVD).
-
Behavioural science in cancer screening, control and communication
Dr Dodd has an established international reputation as a behavioural scientist in cancer control and communication. Since completing her PhD in 2016, Dr Dodd has been awarded a three-year University of Sydney Postdoctoral Research Fellowship (2018-2021) and a three-year Research Fellowship at The Daffodil Centre (current). Dr Dodd is the co-chair of the ‘Strengthening and optimising approaches to cancer prevention, screening, and early detection’ hub at The Daffodil Centre (with more than 130 staff and students).
-
World-first clinical trial improves patient outcomes for kidney transplants (2023)
A world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant.
Around one in three people who receive a kidney transplant suffer delayed graft function, which means the transplant doesn’t work immediately and they require dialysis.
The lead-author of the study, was Royal Adelaide Hospital Nephrologist and University of Adelaide researcher, Dr Michael Collins.
